Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 11, 2013

View Archived Issues

Dual M3 receptor/beta2-adrenoceptor antagonists/agonists disclosed by Chiesi Farmaceutici

Research alliance expands miRNA targets

Encouraging phase IIb results for Nexagon in chronic venous leg ulcers

Inovio Pharmaceuticals prepares for clinical trial of HCV vaccine

Galapagos receives grant from Flemish government to support antibacterial research

Adimab expands collaborations with Merck & Co. and Lilly

BIND Biosciences and Amgen to develop a kinase inhibitor nanomedicine

Cell Therapeutics begins enrollment in phase III PERSIST-1 trial

FDA grants fast track designation to enobosarm for muscle wasting in NSCLC

Novel 11-beta-HSD1 inhibitor with potential for treating diabetes identified at Pfizer

Experiments with FH-535 implicate Wnt signaling pathway in triple-negative breast cancer

CHAMPION PHOENIX phase III trial meets primary endpoint

Altravax receives NIH grants for additional testing of vaccine candidates

Chinese researchers patent new coumarin derivatives

OPKO Health to expand pipeline with acquisition of Cytochroma

ALS Therapy Development Institute and to-BBB sign collaboration agreement

FDA accepts resubmission of NDA for sugammadex sodium injection

Eli Lilly discloses novel metabotropic glutamate receptor agonists

Novel prodrugs of vilazodone presented by Nectid

Combining gamma-secretase inhibitors with endocrine therapy shows promise in relapsed MBC

SK Biopharmaceuticals divulges new 1-beta-HSD1 inhibitors

NewVac and Janssen sign license and development agreement

Pierre Fabre Medicament synthesizes novel alpha-adrenoceptor antagonists

Oramed submits IND application for phase II trial of oral insulin candidate

FDA advisory committee recommends approval of canagliflozin

Phase I data reported for breast cancer treatment MM-302

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 8, 2026.
ASCO 2026: Chinese biopharma arrives at ASCO with pivotal wins
BioWorld
If the 2026 American Society of Clinical Oncology (ASCO) annual meeting in Chicago from May 30 to June 3 demonstrated anything about the evolution of China’s...
New York University identifies new analogues of mannose-6-phosphate
BioWorld Science
New York University has discovered new analogues of mannose-6-phosphate reported to be potentially useful for the treatment of memory impairment,...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...